简体中文English

QKI (6q26) gene breakage probe reagent
Wholesale Price(RMB):

30006000330066003300660036007200

Product Code:R-0501385Ⅰ-01/R-0501385Ⅰ-02/R-0501385Ⅱ-01/R-0501385Ⅱ-02/R-0501385Ⅲ-01/R-0501385Ⅲ-02/R-0501385Ⅳ-01/R-0501385Ⅳ-02
Probe name:GSP QKI(Centromere)/ GSP QKI(Telomere)
Product Code:Type I (direct FISH method)/Type II (biotin-labeled indirect FISH method)/Type III (digoxigenin-labeled indirect FISH method)/Type IV (TSA-FISH method)
Registration Number:
Clinical Value

Angiocentric glioma (AG) is a newly classified and very rare first-degree central nervous system (CNS) lesion, defined in the 2016 WHO Neurological Tumors fascicle as "epilepsy-associated, stable or slow-growing tumors of the brain that occur in children and young adults. It is accompanied by QKI gene rearrangement, which can be designed to be detected by QKI breakage probes, providing an auxiliary molecular diagnosis for angiocentric glioma.